Logo

BioReference Laboratories

Meet Ravgen, the Little-Known Company Rattling NIPTs Biggest Players in Court
Premium

The firm alleges its competitors infringe its patents describing processes for finding chromosomal abnormalities in fetal cell-free DNA.

Opko Health Q3 Revenues Fall 10 Percent

Despite decreases in COVID-19 testing volume, the firm saw an increase in clinical and genomic test revenue.

BioReference Labs Acquires US Ariosa Lab NIPT Business From Roche

The business will complement BioReference's specialty health division GenPath, which offers a noninvasive prenatal screening test.

Increased Testing Revenues Boost Opko Health Q2 Revenues 47 Percent

The firm saw increases in SARS-CoV-2, clinical, and genomic testing and processed approximately 2.8 million COVID-19 PCR tests.

Opko Health Q1 Revenues More Than Double Due to COVID-19 Test Demand

The company reported revenues of $545.2 million compared to $211.5 million in the year-ago quarter, primarily driven by COVID-19 testing.

Apr 1, 2021

BioReference Labs Inks Deal to Provide Rapid PCR, Point-of-Care COVID-19 Testing for MLB

Feb 18, 2021

Opko Health Q4 Revenues More Than Double Thanks to COVID-19 Testing

Dec 20, 2020

How Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19?
Premium

Oct 30, 2020

Opko Health Q3 Revenues Up 87 Percent

Aug 12, 2020

GeneDx Inks Neonatal Genomic Services Deal With Pediatrix Medical Group

Mar 14, 2020

Trump Administration Highlights Role of Private Sector in Effort to Increase Coronavirus Testing

Mar 13, 2020

BioReference Partners With NY State to Provide Drive-Through SARS-CoV-2 Testing

Mar 5, 2020

Commercial Labs Step up Coronavirus Test Efforts After FDA Guidance

Dec 6, 2019

Local Coverage Determinations Roundup: Transplant Genomics, Opko Health

Apr 3, 2019

NIPT Laboratories Don't Follow All ACMG Recommendations for Reporting, Patient Education

Aug 28, 2018

BioReference Labs' GenPath to Participate in NCI-MATCH

Jun 22, 2018

Some Stakeholders Not on Board With Draft Bill on New Dx Regulatory Framework
Premium

Jan 12, 2018

GeneDx, Radboud UMC Collaborate on Research Into Neurodevelopmental Disorders

Nov 22, 2017

Longstanding Genetic Testing Website GeneTests Closing

Sep 19, 2017

BioReference, The Garage Form Alliance to Advance Patient Care

Jun 7, 2017

UC Health to Have Expanded Access to GeneDx Tests

Apr 24, 2017

Diaceutics Inks Deal for BioReference Labs Dx Data

Jan 10, 2017

Natera Terminates Bio-Reference Labs NIPT Distribution Agreement

Jan 4, 2017

Genetic Testing Firms Establish NIPT Advocacy Organization

Jan 4, 2017

Natera Files Suit Against Bio-Reference Laboratories for Breach of Contract

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.